Funding

Giraffe Bio

Argentina · Biotech

Giraffe Bio develops biochemical reagents for mineral recovery.

Visit giraffe.bioFunding history

Product

The company combines AI molecular design, cell-free biology and testing on ore samples to create reagents tailored to specific minerals. Its initial focus is copper flotation, where the products work alongside existing chemicals and equipment.

Founded in 2024, Giraffe Bio operates in Argentina and Chile and is moving from laboratory validation toward larger industrial pilots.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$6.4MOrion Industrial Ventures — LeadAir Capital — ParticipantBaruch Future Ventures — ParticipantBHP Ventures — ParticipantTwynam — Participant

Investors

Orion Industrial VenturesLed SeedAir CapitalJoined SeedBaruch Future VenturesJoined SeedBHP VenturesJoined SeedTwynamJoined Seed

Coverage

Oct 13, 2026Giraffe Bio · Seed

Similar companies

AdipoSeedsAdipoSeeds develops platelet-based regenerative medicine and platelet-processing technology.Undisclosed · Strategic investment
Estuary BiotherapeuticsEstuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.$93M · Series A
MicrobioticaMicrobiotica develops oral medicines made from selected live bacteria for inflammatory diseases and cancer treatment.£36M · Series C first close
Sourcesglobenewswire.com ↗